1. Home
  2. SLDB vs GDOT Comparison

SLDB vs GDOT Comparison

Compare SLDB & GDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • GDOT
  • Stock Information
  • Founded
  • SLDB 2013
  • GDOT 1999
  • Country
  • SLDB United States
  • GDOT United States
  • Employees
  • SLDB N/A
  • GDOT N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • GDOT Finance: Consumer Services
  • Sector
  • SLDB Health Care
  • GDOT Finance
  • Exchange
  • SLDB Nasdaq
  • GDOT Nasdaq
  • Market Cap
  • SLDB 366.2M
  • GDOT 363.9M
  • IPO Year
  • SLDB 2018
  • GDOT 2010
  • Fundamental
  • Price
  • SLDB $3.65
  • GDOT $8.23
  • Analyst Decision
  • SLDB Strong Buy
  • GDOT Hold
  • Analyst Count
  • SLDB 9
  • GDOT 3
  • Target Price
  • SLDB $15.67
  • GDOT $9.33
  • AVG Volume (30 Days)
  • SLDB 1.3M
  • GDOT 884.7K
  • Earning Date
  • SLDB 05-14-2025
  • GDOT 05-08-2025
  • Dividend Yield
  • SLDB N/A
  • GDOT N/A
  • EPS Growth
  • SLDB N/A
  • GDOT N/A
  • EPS
  • SLDB N/A
  • GDOT N/A
  • Revenue
  • SLDB N/A
  • GDOT $1,718,370,000.00
  • Revenue This Year
  • SLDB N/A
  • GDOT $12.61
  • Revenue Next Year
  • SLDB $569.02
  • GDOT $14.11
  • P/E Ratio
  • SLDB N/A
  • GDOT N/A
  • Revenue Growth
  • SLDB N/A
  • GDOT 14.69
  • 52 Week Low
  • SLDB $2.45
  • GDOT $6.12
  • 52 Week High
  • SLDB $10.99
  • GDOT $13.58
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 49.73
  • GDOT 52.01
  • Support Level
  • SLDB $2.48
  • GDOT $7.23
  • Resistance Level
  • SLDB $2.88
  • GDOT $7.67
  • Average True Range (ATR)
  • SLDB 0.31
  • GDOT 0.49
  • MACD
  • SLDB 0.10
  • GDOT 0.02
  • Stochastic Oscillator
  • SLDB 86.97
  • GDOT 56.73

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

Share on Social Networks: